Equitable Holdings, Inc.
Position in LCTX — Lineage Cell Therapeutics, Inc.
CIK 1333986
NEW YORK, NY
Position in LCTX
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$39,315
-$8,103 QoQ
Shares Held
30,012
0.0% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#65
of 130 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LCTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Equitable Holdings, Inc. holds $9,067,537 across 15 Biotechnology names. LCTX ranks #12 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LGND |
Ligand Pharmaceuticals Inc
|
9,304 | $2,940,901 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,920 | $1,450,451 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,747 | $1,089,324 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
5,140 | $962,619 | |
| 5 | CRSP |
CRISPR Therapeutics AG
|
16,341 | $891,238 | |
| 6 | VKTX |
Viking Therapeutics, Inc.
|
11,000 | $429,110 | |
| 7 | EXEL |
Exelixis, Inc.
|
7,495 | $407,802 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
1,304 | $314,224 |
All Filings in LCTX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $39,315 | 30,012 | Shares | Defined | 2026-08-17 | |
| 2026-03-31 | $47,418 | 30,012 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $50,140 | 30,024 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $50,740 | 30,024 | Shares | Defined | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||